BiotechTube
Home/TriSalus Life Sciences/Boris (Bo) R. Shkolnik
B(

Boris (Bo) R. Shkolnik

Founder

TriSalus Life Sciences

Therapeutic Areas

OncologyLiver CancerPancreatic Cancer

TriSalus Life Sciences Pipeline

DrugIndicationPhase
Nelitolimod (SD-101) via PEDD™ PRVI + systemic checkpoint inhibitorsLocally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Phase 1
Nelitolimod (SD-101) via PEDD™ + systemic checkpoint inhibitorsHepatocellular Carcinoma (HCC)Phase 1/2

Leadership Team at TriSalus Life Sciences

SC
Steven C. Katz
Chief Executive Officer
MT
Mary T. Szela
Executive Chair of the Board
G(
Gerard (Jerry) Michel
Chief Financial Officer
View full TriSalus Life Sciences profile